Abstract
The aim was to evaluate the pretreatment efficacy of endorectal coil (ERC) MRI in accurately predicting extracapsular extension in a group of intermediate risk patients. A total of 40 intermediate risk patients were identified who underwent pretreatment ERC MRI and subsequent radical prostatectomy (RP). Imaging studies and pathologic analysis were compared with respect to presence of extracapsular extension (ECE), involvement of seminal vesicles, and appearance of regional nodes. Mean age was 62 years, PSA 14.8, and most common stage was cT2a/pT2c and Gleason 6. ERC MRI has a positive predictive value of 81%, specificity 89%, and odds ratio 6.47 in determining extracapsular extension. Conversely, its sensitivity is only 43%, with a negative predictive value of 59%. ERC MRI may be useful as an adjunctive study for intermediate risk patients due to its high specificity and positive predictive value, thereby adding information to the clinical decision-making process.
Similar content being viewed by others
References
Bauer JJ, Zeng J, Weir J et al. (1999) Three-dimensional computer-simulated prostate models: lateral prostate biopsies increase the detection rate of prostate cancer. Urology 53:961–967
Beahrs OH, Henson DE, Hutter RVP et al. (1992) Manual for staging of Cancer. In: Lippincott JB (ed) American Joint Committee on Cancer, 4th edn. JB Lippincott, Philadelphia, pp 181–186
Catalona WJ, Smith DS (1998) Cancer recurrence and survival rates after anatomic radical retropubic prostatectomy for prostate cancer: intermediate-term results. J Urol 160:2428–2434
D’Amico AV, Whittington R, Schnall M, Malkowicz SB, Tomaszewski JE, Schultz D, Wein A (1995) The impact of the inclusion of endorectal coil magnetic resonance imaging in a multivariate analysis to predict clinically unsuspected extraprostatic cancer. Cancer 75:2368–2372
D’Amico AV, Whittington R, Malkowicz B et al. (2000) Endorectal magnetic resonance imaging as a predictor of biochemical outcome after radical prostatectomy in men with clinically localized prostate cancer. J Urol 164:759–763
Gleason DF (1997) Histologic grading and clinical staging of prostatic carcinoma. In: Tannenbaum M (ed) Urologic pathology: the prostate, part II. Chapt. 9. Lea & Febiger, Philadelphia, pp 171–198
Greenlee RT, Hill-Harmon MB, Murray T, Thun M (2001) Cancer statistics, 2001. CA Cancer J Clin 51:15–36
Grossfeld GD, Chang JJ, Broering JM et al. (2000) Impact of positive surgical margins on prostate cancer recurrence and the use of secondary cancer treatment: data from the CaPSURE database. J Urol 163:1171–1177
Holmberg L, Bill-Axelson A, Helgesen F et al. (2002) A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer. N Engl J Med 347:781–789
Hull GW, Rabbani F, Abbas F, Wheeler TM, Kattan MW, Scardino PT (2002) Cancer control with radical prostatectomy alone in 1,000 consecutive patients. J Urol 167:528–534
Partin AW, Yoo J, Carter HB, Pearson JD, Chan DW, Epstein JI, Walsh PC (1993) The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. J Urol 150:110–114
Roach M (1993) Letter to the editor. J Urol 150:1923–1924
Sohayda C (2000) Extent of extracapsular extension in localized prostate cancer. Urology 55:382–386
Tempany CM, Zhou X, Zerhouni EA et al. (1994) Staging of prostate cancer: results of Radiology Diagnostic Oncology Group project comparison of three MR imaging techniques. Radiology 192:47–54
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Brassell, S.A., Krueger, W.R., Choi, JH. et al. Correlation of endorectal coil magnetic resonance imaging of the prostate with pathologic stage. World J Urol 22, 289–292 (2004). https://doi.org/10.1007/s00345-004-0440-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00345-004-0440-x